The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 05, 2015

Filed:

Mar. 15, 2010
Applicants:

Masami Kaneko, Ichihara, JP;

Kazuo Ono, Ichihara, JP;

Inventors:

Masami Kaneko, Ichihara, JP;

Kazuo Ono, Ichihara, JP;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 221/02 (2006.01); C07D 233/56 (2006.01); C07D 233/58 (2006.01); C07D 233/60 (2006.01); C07D 233/61 (2006.01); C07D 233/64 (2006.01); C08G 59/42 (2006.01); C08G 59/68 (2006.01); H01L 23/29 (2006.01); C07D 233/54 (2006.01); C08G 59/40 (2006.01); C08G 59/70 (2006.01);
U.S. Cl.
CPC ...
H01L 23/293 (2013.01); C07D 233/60 (2013.01); C07D 233/61 (2013.01); C07D 233/56 (2013.01); C07D 233/64 (2013.01); C07D 233/58 (2013.01); C07D 221/02 (2013.01); C07D 233/54 (2013.01); C08G 59/4014 (2013.01); C08G 59/4223 (2013.01); C08G 59/4007 (2013.01); C08G 59/70 (2013.01);
Abstract

It is an object of the present invention to provide a clathrate that suppresses a curing reaction at low temperature to promote an improvement in storage stability (one-component stability), and can effectively cure a resin by heating treatment. A clathrate suitable for the clathrate is a clathrate containing (b1) at least one selected from the group consisting of an aliphatic polyvalent carboxylic acid, 5-nitroisophthalic acid, 5-tert-butylisophthalic acid, 5-hydroxyisophthalic acid, isophthalic acid, and benzophenone-4,4'-dicarboxylic acid; and (b2) at least one selected from the group consisting of an imidazole compound represented by the following formula (I), and 1,8-diazabicyclo[5.4.0]undecene-7, at a molar ratio of 1:1.


Find Patent Forward Citations

Loading…